[Early appearance of myelodysplastic syndrome secondary to therapy for Burkitt-type acute lymphoblastic leukemia (ALL3)].
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D002051:Burkitt Lymphoma / Q000150:complications / Q000188:drug therapy*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000209:etiology*; D011379:Prognosis; D013997:Time Factors